Our data showed no significant differences in frequencies of NKG2D in the CD56bright NK subset (Fig. 3G), CD56dim NK subset (Fig. 3H) nor in the CD56− NK subset among groups of HC, PD patients with disease duration <4 years or those with disease duration 4+ years (Fig. 3I). Here, KLRK1 is linked to Parkinson disease.